Parisa Mashayekhi, Mehrdad Noruzinia, & Sepideh Khodaverdi. (2022). Metformin as a potential agent for modulating the faulty endometriotic mesenchymal stem cells: A case-control study. Shahid Sadoughi University of Medical Sciences.
Chicago Style (17th ed.) CitationParisa Mashayekhi, Mehrdad Noruzinia, and Sepideh Khodaverdi. Metformin as a Potential Agent for Modulating the Faulty Endometriotic Mesenchymal Stem Cells: A Case-control Study. Shahid Sadoughi University of Medical Sciences, 2022.
MLA (9th ed.) CitationParisa Mashayekhi, et al. Metformin as a Potential Agent for Modulating the Faulty Endometriotic Mesenchymal Stem Cells: A Case-control Study. Shahid Sadoughi University of Medical Sciences, 2022.
Warning: These citations may not always be 100% accurate.